Gastric Adenocarcinoma

• CLINICAL_TRIALS research · 2018-07-26
  Clinical Trial Update: XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma [Phase 1, Phase 2]

  A phase 1/2 clinical trial investigating XELOX chemotherapy with apatinib as postoperative treatment for locally advanced gastric adenocarci…

• CLINICAL_TRIALS research · 2018-03-12
  Clinical Trial Update: Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma [NA]

  Clinical trial update on CAR-CLD18 T cells for advanced gastric adenocarcinoma and pancreatic adenocarcinoma; current trial status is unknow…

• CLINICAL_TRIALS research · 2017-03-01
  Clinical Trial Update: Diffusion Weighted Magnetic Resonance Imaging for Preoperative Staging in Gastric Adenocarcinoma Patients [EARLY_Phase 1]

  This clinical trial update reports the completion of an early-phase study evaluating diffusion-weighted magnetic resonance imaging for preop…

• CLINICAL_TRIALS research · 2014-12-02
  Clinical Trial Update: Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma [Phase 1, Phase 2]

  Clinical trial update on MBP-426 for second-line gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, and esophageal adenocarci…

• CLINICAL_TRIALS research · 2014-09-15
  Clinical Trial Update: Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric Cancer [Phase 3]

  Phase 3 trial update on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) for locally advanced gastric cancer; no efficacy r…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2012-04-24
  Clinical Trial Update: SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer [Phase 3]

  Phase 3 clinical trial evaluating the SOX regimen (S-1 plus oxaliplatin) as neoadjuvant chemotherapy for AJCC stage II-III gastric cancer.

• CLINICAL_TRIALS research · 2008-10-21
  Clinical Trial Update: Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]

  Phase II neoadjuvant trial of docetaxel (Taxotere), cisplatin, and 5-fluorouracil for gastric or gastroesophageal junction adenocarcinoma; n…